COA on fileShips from United States

HGH 191AA (Somatropin)

Recombinant human growth hormone — the 191-amino-acid mature somatropin protein, not a peptide

Recombinant somatropin: a 191-amino-acid protein with the sequence of the 22 kDa mature human growth hormone isoform. It is a protein rather than a peptide, and its potency is assigned in International Units against a WHO reference standard rather than by mass.

HGH 191AA is recombinant human somatropin — a 191-amino-acid protein whose primary sequence is identical to the mature 22 kDa isoform of endogenous human growth hormone (UniProt P01241, residues 27–217 of the 217-residue precursor, after signal peptide cleavage). It folds into a four-helix bundle stabilised by two intramolecular disulfide bridges and acts as an agonist at the growth hormone receptor, dimerising it to initiate JAK2/STAT5 signalling. It is produced recombinantly, commonly in E. coli or mammalian expression systems. The '191AA' designation distinguishes it from somatrem, an older 192-residue methionyl variant that carries an extra N-terminal methionine.

Two classification points that this catalogue takes seriously. First, this is a protein, not a peptide: at roughly 22 kDa and 191 residues with defined tertiary structure and disulfide topology, it belongs to a different analytical and stability regime than the synthetic peptides listed elsewhere, and higher-order structure, aggregation state and host-cell protein content are meaningful quality attributes for it in a way they are not for a 29-mer. Second, somatropin potency is assigned biologically in International Units against a WHO International Standard rather than by peptide content, which is why licensed presentations are labelled in IU and why a mass figure alone does not specify what is in a vial.

Somatropin is a genuinely approved medicine, registered in many jurisdictions under numerous brand names for paediatric and adult growth hormone deficiency and several other indications, with decades of regulated clinical use behind it. The honest limitation is that none of that transfers to research-grade material. An unlicensed preparation has no potency traceable to the WHO standard, no verified aggregation, deamidation or oxidation profile, and no characterised host-cell protein or endotoxin burden — and for a recombinant protein those attributes are the principal determinants of immunogenicity. Sequence identity with an approved product is not equivalence to it.

Specification

CAS number12629-01-5
Molecular weight≈22.1 kDa (191 residues)
AppearanceLyophilised white powder
StorageStore at -20°C, protect from light

Batch records & certificates

Every lot we hold of this compound, across all warehouses. The certificate is tied to that lot number — not a generic sample document.

LotWarehousePurityTestedLaboratoryDocuments
HGH24-082026All warehouses96.86%13 Aug 2026Janoshik AnalyticalCOA
All products listed on this site are sold strictly as laboratory reagents for in-vitro research and analytical use. They are not drugs, foods, cosmetics or medical devices, and are not intended to diagnose, treat, cure or prevent any disease. They are not for human or veterinary consumption or administration. Purchasers must be qualified researchers or institutions and are solely responsible for compliance with all applicable laws.